Henry Schein (NASDAQ:HSIC) Updates FY24 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $5.00 to $5.16 for the period, compared to the consensus earnings per share estimate of $5.06. The company issued revenue guidance of +8-10% yr/yr or $13.326 billion to $13.573 billion from +8, compared to the consensus revenue estimate of $13.42 billion.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on HSIC shares. Barrington Research lifted their target price on shares of Henry Schein from $90.00 to $92.00 and gave the company an outperform rating in a report on Wednesday. SVB Leerink started coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a market perform rating and a $78.00 price objective for the company. UBS Group lowered their price target on Henry Schein from $82.00 to $80.00 and set a neutral rating on the stock in a report on Wednesday. TheStreet upgraded shares of Henry Schein from a c+ rating to a b- rating in a report on Monday, February 26th. Finally, Piper Sandler boosted their target price on shares of Henry Schein from $78.00 to $86.00 and gave the company an overweight rating in a research note on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Hold and a consensus target price of $81.73.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $0.43 during midday trading on Friday, reaching $73.01. 165,664 shares of the stock traded hands, compared to its average volume of 1,099,877. The company’s 50 day moving average is $72.95 and its 200 day moving average is $72.35. Henry Schein has a one year low of $60.01 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The stock has a market capitalization of $9.38 billion, a PE ratio of 23.16, a P/E/G ratio of 1.68 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period last year, the company posted $1.21 EPS. On average, equities research analysts anticipate that Henry Schein will post 5.07 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.